Corticotropin releasing factor receptor 1-deficient mice
AssigneeResearch Development Foundation
InventorsWylie Vale, Kuo-Fen Lee
Life of this patent
Estimating the term…
Loading patent…
AssigneeResearch Development Foundation
InventorsWylie Vale, Kuo-Fen Lee
Estimating the term…
Signaling pathways dependent on members of the corticotropin releasing factor (CRF) gene family exert pleiotropic effects within both the brain and peripheral tissues. Two biochemically and pharmacologically distinct corticotropin releasing factor receptor subtypes (corticotropin releasing factor receptor-1 and corticotropin releasing factor receptor-2) have been described. To study the developmental and physiological role of the specific receptor subtypes, a strain of mice null for the corticotropin releasing factor receptor-1 gene has been generated. This genetically engineered strain of mice suggest that corticotropin releasing factor receptor-1 is obligatory both in development and function of the hypothalamic-pituitary-adrenal axis and in mediating behavioral changes associated with anxiety and locomotor activity rhythms.
A transgenic mouse whose somatic and germ cells have a substantial deficiency in the corticotropin releasing factor receptor-1, wherein both alleles of the corticotropin releasing factor receptor-1 are disrupted resulting in a mouse with decreased anxiety, reduced endocrine response to stress and increased locomoter activity rhythms as compared to a control mouse.
A method of producing a transgenic mouse in whose genome one or both alleles of the corticotropin releasing factor receptor-1 gene have been disrupted, said method comprising:
Dependencies are inferred from the claim text.